Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Remitting Relapsing Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01235455
What this trial is testing

Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)Secondary Progressive Multiple Sclerosis (SPMS)
Bayer 10
Testing effectiveness (Phase 2)Study completedNCT00228163
What this trial is testing

Long Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses

Who this might be right for
Multiple Sclerosis
Sanofi 147
Testing effectiveness (Phase 2)Study completedNCT00071838
What this trial is testing

Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
National Institute of Neurological Disorders and Stroke (NINDS) 16
Testing effectiveness (Phase 2)Study completedNCT01198132
What this trial is testing

A Multicentre Study of the Efficacy and Safety of Supplementary Treatment With Cholecalciferol in Patients With Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta-1a 44 µg 3 Times Weekly

Who this might be right for
Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 129
Large-scale testing (Phase 3)Ended earlyNCT04032158
What this trial is testing

Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis (RMS)

Who this might be right for
Relapsing-remitting Multiple Sclerosis
EMD Serono Research & Development Institute, Inc. 3
Testing effectiveness (Phase 2)Ended earlyNCT02418325
What this trial is testing

Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Genesis Limited 69
Large-scale testing (Phase 3)Not Yet RecruitingNCT07503340
What this trial is testing

Evaluate Pharmacokinetics, Safety, Tolerability, Immunogenicity and Pharmacodynamic Effects of Subcutaneous Ocrelizumab Administration in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Hoffmann-La Roche 25
Not applicableStudy completedNCT01538355
What this trial is testing

A Pilot Trial to Test the Feasibility of Prolonged Fasting and Ketogenic Diet in Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Charite University, Berlin, Germany 48
Testing effectiveness (Phase 2)Study completedNCT00676715
What this trial is testing

The Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Genentech, Inc. 220
Large-scale testing (Phase 3)Study completedNCT05242133
What this trial is testing

Efficacy and Safety of Peginterferon Beta-1a (CinnaGen) in Participants With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)
Cinnagen 168
Not applicableStudy completedNCT00675883
What this trial is testing

COMPliance With Avonex® PS in Patients With Relapsing-Remitting MS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 1,000
Not applicableStudy completedNCT01080001
What this trial is testing

A Observational, Prospective Study to Assess the Impact of Fatigue in the Quality of Life of Patients With Multiple Sclerosis in Argentina

Who this might be right for
Multiple Sclerosis, Relapsing-remitting
Merck KGaA, Darmstadt, Germany 71
Large-scale testing (Phase 3)Study completedNCT01490502
What this trial is testing

Vitamin D Supplementation in Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Johns Hopkins University 172
Testing effectiveness (Phase 2)WithdrawnNCT04880577
What this trial is testing

Tenofovir Alafenamide for Treatment of Symptoms and Neuroprotection in Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingFatigue
Massachusetts General Hospital
Early research (Phase 1)Study completedNCT03551275
What this trial is testing

Dose Escalation Study of the Pharmacodynamics, Pharmacokinetics, Safety, and Immunogenicity of BCD-132 in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Biocad 24
Not applicableStudy completedNCT03284970
What this trial is testing

Retrospective Study to Determine Effect of Rebif and Tecfidera on Infections and Lymphocytes

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
EMD Serono Research & Development Institute, Inc. 34
Not applicableStudy completedNCT01142583
What this trial is testing

A Canadian Study Assessing the Utility of the Treatment Optimization Recommendations in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany 192
Post-approval studies (Phase 4)UnknownNCT04048577
What this trial is testing

A Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of Natalizumab

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Berkovich, Regina MD, PhD Inc. 10
Not applicableStudy completedNCT07680738
What this trial is testing

Transcranial Direct Current Stimulation for Fatigue, Mood, and Cognition in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, MSMultiple SclerosisMultiple Sclerosis (MS) - Relapsing-remitting+5 more
Universidad de Almeria 38
Post-approval studies (Phase 4)UnknownNCT05340985
What this trial is testing

Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingAdult ALLVitamin D3 Deficiency
Tehran University of Medical Sciences 54
Next Page